According to Insmed's latest financial reports the company's current EPS (TTM) is -HK$40.95. In 2022 the company made an earnings per share (EPS) of -HK$30.31 a decrease over its 2021 EPS that were of -HK$30.07.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$41.28 | 36.23% |
2022 | -HK$30.31 | 0.78% |
2021 | -HK$30.07 | 28.57% |
2020 | -HK$23.39 | -0.99% |
2019 | -HK$23.62 | -27.96% |
2018 | -HK$32.79 | 47.55% |
2017 | -HK$22.22 | 0.7% |
2016 | -HK$22.07 | 39.9% |
2015 | -HK$15.77 | 9.73% |
2014 | -HK$14.38 | 17.09% |
2013 | -HK$12.28 | 0.64% |
2012 | -HK$12.20 | -46.42% |
2011 | -HK$22.77 | 497.96% |
2010 | -HK$3.81 | -105.1% |
2009 | HK$74.68 | -850.78% |
2008 | -HK$9.95 | -24.71% |
2007 | -HK$13.21 | -71.67% |
2006 | -HK$46.62 | -28.57% |
2005 | -HK$65.27 | 23.53% |
2004 | -HK$52.84 | 134.48% |
2003 | -HK$22.53 | -73.64% |
2002 | -HK$85.48 | -2.65% |
2001 | -HK$87.81 | -86.64% |
2000 | -HK$657.46 |